The effects and side effects of laquinimod for the treatment of multiple sclerosis patients: a systematic review and meta-analysis of clinical trials Faeze RouhiZinat MohammadpourSama Bitarafan Review 04 February 2020 Pages: 611 - 622
High-risk medication in community care: a scoping review Irina DumitrescuMinne CasteelsTinne Dilles Review 05 February 2020 Pages: 623 - 638
Docosahexaenoic acid supplementation in age-related cognitive decline: a systematic review and meta-analysis Rakesh BalachandarSoundarya SoundararajanBhavani Shankara Bagepally Review 14 February 2020 Pages: 639 - 648
Alpha-lipoic acid effect on leptin and adiponectin concentrations: a systematic review and meta-analysis of randomized controlled trials Fahimeh HaghighatdoostAli GholamiMitra Hariri Review 10 February 2020 Pages: 649 - 657
Multiple genetic factors affecting the pharmacokinetic and pharmacodynamic processes of tacrolimus in Chinese myasthenia gravis patients Huan-Yu MengXi LiHuan Yang Pharmacogenetics 18 January 2020 Pages: 659 - 671
Impact of genotype-predicted CYP2D6 metabolism on clinical effects and tolerability of metoprolol in patients after myocardial infarction – a prospective observational study Anne Kristine AnstensrudEspen MoldenErik Øie Pharmacogenetics 15 January 2020 Pages: 673 - 683
A limited sampling strategy to estimate exposure of once-daily modified release tacrolimus in renal transplant recipients using linear regression analysis and comparison with Bayesian population pharmacokinetics in different cohorts Frank StifftFranciscus VandermeerMaarten H. L. Christiaans Pharmacokinetics and Disposition 04 February 2020 Pages: 685 - 693
Assessment of micafungin loading dosage regimens against Candida spp. in ICU patients by Monte Carlo simulations Xiaoqing LuGaoqi XuLiqin Zhu Pharmacokinetics and Disposition 11 February 2020 Pages: 695 - 702
Expression of fibroblast growth factor receptor 4 and clinical response to lenvatinib in patients with anaplastic thyroid carcinoma: a pilot study Haruhiko YamazakiTomoyuki YokoseMunetaka Masuda Pharmacokinetics and Disposition 07 February 2020 Pages: 703 - 709
Use of antidepressants and mood stabilizers in persons with first-episode schizophrenia Arto PuranenMarjaana KoponenHeidi Taipale Pharmacoepidemiology and Prescription Open access 15 January 2020 Pages: 711 - 718
Selective serotonin reuptake inhibitors and the risk of restless legs syndrome: a symmetry analysis Ann-Cathrine Dalgård DunvaldDaniel Pilsgaard HenriksenLars Christian Lund Pharmacoepidemiology and Prescription 16 February 2020 Pages: 719 - 722
Risk factors for sodium overcorrection in non-hypovolemic hyponatremia patients treated with tolvaptan Yukyung KimNari LeeHye Sun Gwak Pharmacoepidemiology and Prescription 13 February 2020 Pages: 723 - 729
Phenytoin intoxication associated with omeprazole administration in a child with defective CYP2C9 M. MaranoF. NicolettiD. Cocciadiferro Letter to the Editor 15 January 2020 Pages: 731 - 732
Are dizziness-related symptoms signals for suboptimal treatment of hypothyroidism? New insights from the FDA adverse event reporting system (FAERS) database Carla CarnovaleVera BattiniSonia Radice Letter to the Editor 23 January 2020 Pages: 733 - 734
Chronic Chagas disease with low plasma concentrations of IL-6 does not have a major impact on nebivolol glucuronidation Carolina Pinto VieiraDaniel Valente NevesVera Lucia Lanchote Letter to the Editor 25 January 2020 Pages: 735 - 737
Less is more: a cost benefit analysis of a changed posology for nivolumab N. W. BooneA. A. van Bodegraven Letter to the Editor 28 January 2020 Pages: 739 - 740
Spontaneous adverse drug reaction reports on patients with cirrhosis: analysis of the nature, quantity and quality of the reports R. A. WeersinkK. TaxisS. D. Borgsteede Letter to the Editor 13 February 2020 Pages: 741 - 743